Alterations in Mitogen-Activated Protein Kinase Kinase and Extracellular Regulated Kinase Signaling in Theca Cells Contribute to Excessive Androgen Production in Polycystic Ovary Syndrome

Nelson-Degrave, Velen L., Wickenheisser, Jessica K., Hendricks, Karen L., Asano, Tomoichiro, Fujishiro, Midori, Legro, Richard S., Kimball, Scot R., Strauss, Jerome F., McAllister, Jan M.·2005·Molecular Endocrinology
DOI 10.1210/me.2004-0178

Cited by (166)

Items 101–166 of 166

  1. Dihydrotestosterone Inhibits Insulin-Stimulated Cyclin D2 Messenger Ribonucleic Acid Expression in Rat Ovarian Granulosa Cells by Reducing the Phosphorylation of Insulin Receptor Substrate-1
    Pradeep P. Kayampilly, K.M.J. Menon · 2005 · Endocrinology
  2. Mechanism and recent updates on insulin-related disorders
    Shashank Kumar, Sabyasachi Senapati, Neetu Bhattacharya, Amit Bhattacharya, Shashank Kumar Maurya, Hadiya Husain, Jasvinder Singh Bhatti, Abhay Kumar Pandey · 2023 · World Journal of Clinical Cases
  3. Chronic anovulation and the polycystic ovary syndrome
    NATHAN G. KASE · 2013 · Cambridge University Press eBooks
  4. Dehydroepiandrosterone reduces accumulation of lipid droplets in primary chicken hepatocytes by biotransformation mediated via the cAMP/PKA-ERK1/2 signaling pathway
    Longlong Li, Chongyang Ge, Dian Wang, Lei Yu, Jinlong Zhao, Haitian Ma · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  5. Dehydroepiandrosterone-Regulated Testosterone Biosynthesis via Activation of the ERK1/2 Signaling Pathway in Primary Rat Leydig Cells
    Lin Liu, Jian Kang, Xiao Lan Ding, Di Chen, Yingqiao Zhou, Haitian Ma · 2015 · Cellular Physiology and Biochemistry
  6. MAPK and ERK polymorphisms are associated with PCOS risk in Chinese women
    Lingmin Hu, Yiting Zhang, Li Chen, Wei Zhou, Yong Wang, Juan Wen · 2017 · Oncotarget
  7. The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
    Robert L. Rosenfield · 2024 · Endocrine Reviews
  8. Mapping research trends of insulin resistance in polycystic ovary syndrome from 2017 to 2021: A bibliometric analysis
    Yong Chen, Qian Zhang, Jinhui Ma, Yuexin Yu · 2022 · Frontiers in Endocrinology
  9. Cryptotanshinone Regulates Androgen Synthesis through the ERK/c‐Fos/CYP17 Pathway in Porcine Granulosa Cells
    Danfeng Ye, Meifang Li, Yuehui Zhang, Xinhua Wang, Hua Liu, Wanting Wu, Wan-ying Ma, Kewei Quan, Ernest Hung Yu Ng, Xiaoke Wu et al. · 2017 · Evidence-based Complementary and Alternative Medicine
  10. Cumulus cell pappalysin-1, luteinizing hormone/choriogonadotropin receptor, amphiregulin and hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 mRNA levels associate with oocyte developmental competence and embryo outcomes
    Richard J. Kordus, Akhtar Hossain, Michael C. Corso, Hrishikesh Chakraborty, Gail F. Whitman-Elia, Holly A. LaVoie · 2019 · Journal of Assisted Reproduction and Genetics
  11. Insulin Action in Polycystic Ovary Syndrome: In Vivo and In Vitro
    Jean‐Patrice Baillargeon · 2007 · Springer eBooks
  12. PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review1
    Joanie Faubert, Marie‐Claude Battista, Jean‐Patrice Baillargeon · 2016 · Journal of Animal Science
  13. Regulation of interleukin-11 expression in ovulatory follicles of the rat ovary
    You-Jee Jang, Jae-Il Park, Seong-Eun Jeong, You‐Mi Seo, Phuong T.M. Dam, Young-Woo Seo, Bum Chae Choi, Sang-Jin Song, Sang‐Young Chun, Moon-Kyoung Cho · 2017 · Reproduction Fertility and Development
  14. Polycystic ovary syndrome preceding the diagnosis of acromegaly: a retrospective study in 97 reproductive-aged women
    Anamil M. Khiyami, Tahereh Orouji Jokar, Hussein M. Abdallah, Paul A. Gardner, Georgios Andrea Zenonos, Aaron Kyle Styer, Pouneh K. Fazeli · 2023 · Reproductive Biology and Endocrinology
  15. Le syndrome des ovaires polykystiques (SOPK)
    Antoine Torre, Hervé Fernandez · 2007 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
  16. On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome
    Robert L. Rosenfield, Daniel Anthony Dumesic · 2025 · The Journal of Clinical Endocrinology & Metabolism
  17. miRNA-mRNA Network in PBMCs of PCOS Women Identifies Overactivated Stress-Activated Kinases
    Meera B. Krishna, Betcy Susan Johnson, Madavan Vasudevan, Sathy M. Pillai, Malini Laloraya · 2023 · Cellular Physiology and Biochemistry
  18. Network pharmacology-based strategic prediction and target identification of apocarotenoids and carotenoids from standardized Kashmir saffron (Crocus sativus L.) extract against polycystic ovary syndrome
    Anshuly Tiwari, Siddharth J. Modi, Aboli Girme, Lal Hingorani · 2023 · Medicine
  19. Influence of pretreatment of insulin on the phosphorylation of extracellular receptor kinase by gonadotropin-releasing hormone and gonadotropins in cultured human granulosa cells
    Yuri Ko, Ju Hee Kim, Sa Ra Lee, Sung Hoon Kim, Hee Dong Chae · 2021 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  20. Alterations of insulin sensitivity, clearance, and secretion, either alone or in combination, in women with PCOS: impact on metabolic profile and androgenemia
    Flavia Tosi, Maria Giovanna Lando, Federica Rosmini, Federico Lucarini, Veronica Fiorio, Maria Elisabetta Zanolin, Tom Fiers, Jean‐Marc Kaufman, Paolo Moghetti · 2025 · Human Reproduction
  21. Androgen-induced upregulation of CFTR in pancreatic β-cell contributes to hyperinsulinemia in PCOS model
    Mengzhu Sun, Yong Wu, Chun Lan Yuan, Jingya Lyu, Xinyi Zhao, Ye Chun Ruan, Jinghui Guo, Hui Chen, Wen Qing Huang · 2023 · Endocrine
  22. The Src tyrosine kinase pathway regulates thecal CYP17 expression and androstenedione secretion
    G. Chaturvedi, K. Arai, P. Terranova, K. Roby · 2008 · Molecular and Cellular Biochemistry
  23. Characterization of GAB1 Expression Over the Menstrual Cycle in Women With and Without Polycystic Ovarian Syndrome Provides a New Insight Into Its Pathophysiology
    K. L. Roemer, Steven L. Young, Ricardo Francalacci Savaris · 2014 · The Journal of Clinical Endocrinology & Metabolism
  24. Modulation Of Gene Expression In Ovarian Cancer By Active And Repressive Histone Marks
    Sharmila A. Bapat · 2010 · Epigenomics
  25. DNA Microarray Analysis of Estrogen Responsive Genes in Ishikawa Cells by Glabridin
    Melissa Su Wei Poh, Phelim Voon Chen Yong, Visweswaran Navaratnam, Chia Yoke Yin · 2017 · Biochemistry Insights
  26. Ovarian Steroidogenic Abnormalities in PCOS
    Jessica K. Wickenheisser, Jan M. McAllister · 2007 · Springer eBooks
  27. Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
    Sylvain Bellanger, Marie‐Claude Battista, Jean‐Patrice Baillargeon · 2013 · Springer eBooks
  28. Uterine progesterone signaling is a target for metformin therapy in PCOS-like rats
    Min Hu, Yuehui Zhang, Jiaxing Feng, Xue Jun Xu, Jiao Zhang, Wei Zhao, Xiaozhu Guo, Juan Li, Edvin Vestin, Peng Cui et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  29. The Endocrinological Basis for Polycystic Ovary Syndrome: An Evolutionary Perspective
    Daniel Anthony Dumesic, Bernard J. Crespi, Vasantha Padmanabhan, David Howard Abbott · 2025 · Endocrinology
  30. Molecular mechanisms of folliculogenesis. From ovulation to the corpus luteum formation
    K. Yu. Boyarsky, E. I. Kachiani · 2018 · Russian Journal of Human Reproduction
  31. Ovulation Rate after Metformin and Clomiphene vs Clomiphene Alone in Polycystic Ovary Syndrome (PCOS): A Randomized, Double-Blind, Placebo-Controlled Trial
    Georgia Heathcote, Clare V. Boothroyd, Kevin L Forbes, Alan Lee, Margaret F. Gregor, Georgina M. Luscombe · 2020 · Fertility & Reproduction
  32. Role of hyperinsulinemic insulin resistance in polycystic ovary syndrome
    Iuorno, Maria J. · 2001 · Polycystic Ovary Syndrome
  33. The Genetics of Polycystic Ovary Syndrome: From Genome-Wide Association to Molecular Mechanisms
    Jerome F. Strauss, Bhavi P. Modi, Janette M. McAllister · 2018 · Reproductive medicine for clinicians
  34. Metabolic Syndrome in Polycystic Ovary Syndrome
    Yun-Chiao Hsieh, Po-Kai Yang, Mei‐Jou Chen · 2021 · Fertility & Reproduction
  35. Expression and Contribution of Insulin Signaling Pathway to the Development of Polycystic Ovary Syndrome
    Qingqiang Lin, Hong Zhang, Jiu-Hua Zhao, Zhengchao Wang · 2019 · IntechOpen eBooks
  36. Etiología del síndrome del ovario poliquístico
    Héctor Francisco Escobar-Morreale · 2006 · Endocrinología y Nutrición
  37. Insulin sensitizers for women with polycystic ovarian syndrome
    Ahmed F. Galal, M.F. Mitwally · 2009 · Expert Review of Endocrinology & Metabolism
  38. Role of Statins in PCOS Management
    Israel Ortega, Antoni J. Dulęba · 2013 · Springer eBooks
  39. Fetal Origins of Polycystic Ovary Syndrome
    David Howard Abbott, Cristin M. Bruns, Deborah K. Barnett, Alice F. Tarantal, Sarah M. Hoffmann, Rao Zhou, Jon E. Levine, Daniel Anthony Dumesic · 2008 · Humana Press eBooks
  40. Insulin resistance in relation to clinical, endocrine and metabolic profile of infertile women with polycystic ovary syndrome
    Shakeela Ishrat, Marufa Hossain, Subrata Kumar Biswas · 2021 · Bangabandhu Sheikh Mujib Medical University Journal
  41. Molecular Basis of Gynecologic Diseases
    Samuel C. Mok, Kwong‐Kwok Wong, Karen H. Lu, Karl Münger, Zoltán Nagymányoki · 2009 · Elsevier eBooks
  42. Molecular Basis of Gynecologic Diseases
    Samuel C. Mok, Kwong‐Kwok Wong, Karen H. Lu, Karl Münger, Zoltán Nagymányoki · 2017 · Elsevier eBooks
  43. Role of Statins and Resveratrol in PCOS Management
    Anna Sokalska, Israel Ortega, Antoni J. Dulęba · 2022 · Springer eBooks
  44. Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
    Anne‐Marie Carreau, Marie‐Claude Battista, Jean‐Patrice Baillargeon · 2022 · Springer eBooks
  45. Polycystic Ovary Syndrome and Metabolic Syndrome
    Marie-Hélène Pesant, Jean‐Patrice Baillargeon · 2009 · Humana Press eBooks
  46. Genes Related to Metabolic Abnormalities or Insulin Resistance in Polycystic Ovary Syndrome
    Héctor Francisco Escobar-Morreale · 2007 · Humana Press eBooks
  47. Polycystic Ovary Syndrome, Obesity and Insulin Resistance
    Samantha Cassar · 2014 · Victoria University Research Repository (Victoria University)
  48. Androgen receptor mediated activity in the ovary : implications for Polycystic Ovary Syndrome
    Theresa E. Hickey · 2006 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  49. Impact of Obesity on Female Reproductive Health
    Moshood O. Olatinwo, Djana Harp, Winston E. Thompson, Hyeong-Kyu Park, Roland P. Mathews · 2010 · Springer eBooks
  50. Avaliação do perfil de miRNAs circulantes em pacientes com síndrome dos ovários policísticos
    Giovana De Nardo Maffazioli · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  51. Effects of Prenatal Testosterone on the Reproductive and Metabolic Neurons of the Sheep Hypothalamus
    Maria Cernea · 2013 · Scholarship@Western (Western University)
  52. Polycystic Ovary Syndrome and Cardiovascular Disease
    Bar nder, Derun Taner, Hamiyet Ylmaz, M. Muzaffer · 2012 · InTech eBooks
  53. Efectos del resveratrol en la fisiología ovárica y su potencial aplicación en el síndrome de ovario poliquístico
    Israel Ortega Sánchez · 2014 · BURJC Digital (King Juan Carlos University)
  54. Insulin Action and Secretion in Polycystic Ovary Syndrome
    Julia Warren-Ulanch, Silva A Arslanian · 2008 · Humana Press eBooks
  55. Reply: Correlates between hyperinsulinism and hyperandrogenemia?
    Jean‐Patrice Baillargeon, André C. Carpentier · 2008 · Fertility and Sterility
  56. L'hormone anti-müllerienne dans le syndrome des ovaires polykystiques. Quelle valeur diagnostique ? Évaluation du dosage de l'hormone anti-müllerienne à l'aide du kit Ultra-sensitive Ansh Labs assays dans le centre d'Aide Médicale à la Procréation du CHU de Nice
    Charlotte Paul · 2015 · HAL
  57. Obezite ve Tipinin Endometrial Kalınlık ve Endometrial Patolojiler ile İlişkisinin Değerlendirilmesi
    Anıl TURHAN ÇAKIR, Sadun Sucu · 2020 · Turkish Journal of Diabetes and Obesity
  58. Polycystic Ovary Syndrome and Metabolic Syndrome
    Anne‐Marie Carreau, Marie-Hélène Pesant, Jean‐Patrice Baillargeon · 2019 · Contemporary Endocrinology
  59. Current World Literature
    2006 · Current Opinion in Endocrinology & Diabetes
  60. Hormonal Effects on Ovarian Follicular Growth and Differentiation
    Jiyang Zhang, Tingjie Zhan, Shuo Xiao · 2025 · Elsevier eBooks
  61. Additional file 1 of Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10
    Chugh, Rishi Man, Park, Hang-soo, Abdeljabar El Andaloussi, Amro Elsharoud, Sahar Esfandyari, Mara Ulin, Lale Vuslat Bakir, Aboalsoud, Alshimaa, Ali, Mohamed, Ashour, Dalia et al. · 2021 · Figshare
  62. Fertility in Polycystic Ovary Syndrome—The Spark and the Fire!
    Duru Shah, Sabahat Rasool · 2025 · Fertility & Reproduction
  63. Expression , régulation et rôle du système adiponectine dans l'ovaire chez trois espèces
    Christine Chabrolle · 2008 · theses.fr (ABES)
  64. The Potential for Polycystic Ovarian Disorder Treatment Through Drug Delivery Using Nanomaterials
    Roopa Roopa Sharma, Seema Rohilla, Dr Sunil Jawla, Lipuna Kundu, Pragati Kumari, Nikhil Rawal · 2026 · International Journal of Drug Delivery Technology
  65. Insulin signaling in PCOS/PMOS: molecular insights and clinical implications
    Abhishek Goel, Ashna Grover, Skand Shekhar · 2026 · Frontiers in Endocrinology
  66. Interconnected metabolic and reproductive signaling axis in type 2 diabetes mellitus and polyendocrine metabolic ovarian syndrome
    Khurshid Ahmad Padder, MohdAshraf Ganie, Nusrat Jahan, Mohmad Aadil Yousuf, Tajali Sehar, Mudasir Ahmad Bhat, Showkat Ahmad Buhroo, Saba Muzaffar, Sadiq Majeed, Refaz Ahmad Dar et al. · 2026 · Frontiers in Endocrinology